{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:55:33Z","timestamp":1760550933714},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can J Public Health"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/bf03404152","type":"journal-article","created":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T16:30:44Z","timestamp":1568305844000},"page":"84-86","source":"Crossref","is-referenced-by-count":3,"title":["Is There a Need for Heroin Substitution Treatment in Vancouver\u2019s Downtown Eastside?"],"prefix":"10.17269","volume":"102","author":[{"given":"Meldon","family":"Kahan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Conway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,3,1]]},"reference":[{"issue":"8","key":"BF03404152_CR1","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1056\/NEJMoa0810635","volume":"361","author":"E Oviedo-Joekes","year":"2009","unstructured":"Oviedo-Joekes E, Brissette S, Marsh DC, Lauzon P, Guh D, Anis A, Schechter MT. Diacetylmorphine versus methadone for the treatment of opioid addiction. N Engl J Med 2009;361(8):777\u201386.","journal-title":"N Engl J Med"},{"issue":"10","key":"BF03404152_CR2","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1111\/j.1360-0443.2005.01232.x","volume":"100","author":"EC Donny","year":"2005","unstructured":"Donny EC, Brasser SM, Bigelow GE, Stitzer ML, Walsh, SL. Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid dependent volunteers. Addiction 2005;100(10):1496\u2013509.","journal-title":"Addiction"},{"issue":"2","key":"BF03404152_CR3","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.drugalcdep.2005.06.005","volume":"81","author":"R Hallinan","year":"2006","unstructured":"Hallinan R, Ray J, Byrne A, Agho K, Attia J. Therapeutic thresholds in methadone maintenance treatment: A receiver operating characteristic analysis. Drug Alcohol Depend 2006;81(2):129\u201336.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"BF03404152_CR4","first-page":"332","volume":"124","author":"H Kornor","year":"2004","unstructured":"Kornor H, Waal H. [Methadone dose, treatment duration and heroin use in drug-assisted rehabilitation]. Tidsskr Nor Laegeforen 2004;124(3):332\u201334.","journal-title":"Tidsskr Nor Laegeforen"},{"issue":"3","key":"BF03404152_CR5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.drugalcdep.2005.09.004","volume":"82","author":"E Peles","year":"2006","unstructured":"Peles E, Schreiber S, Adelson M. Factors predicting retention in treatment: 10 year experience of a methadone maintenance treatment (MMT) clinic in Israel. Drug Alcohol Depend 2006;82(3):211\u201317.","journal-title":"Drug Alcohol Depend"},{"key":"BF03404152_CR6","volume-title":"College of Physicians and Surgeons of British Columbia","author":"Committee on Opioid Dependence. Methadone Maintenance Handbook.","year":"2005","unstructured":"Committee on Opioid Dependence. Methadone Maintenance Handbook. College of Physicians and Surgeons of British Columbia, 2005."},{"key":"BF03404152_CR7","volume-title":"Methadone Maintenance Guidelines","author":"College of PhysiciansSurgeons of Ontario.","year":"2005","unstructured":"College of Physicians and Surgeons of Ontario. Methadone Maintenance Guidelines. Toronto, 2005."},{"issue":"22","key":"BF03404152_CR8","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1056\/NEJMc0908720","volume":"361","author":"C Saldana","year":"2009","unstructured":"Saldana C, Hart C, Kahan M, Reece AS, Oviedo-Joekes E, Marsh D, Schechter M. Diacetylmorphine versus methadone for opioid addiction (letters). N Engl J Med 2009;361(22):2193\u201395.","journal-title":"N Engl J Med"},{"issue":"5","key":"BF03404152_CR9","doi-asserted-by":"publisher","first-page":"735","DOI":"10.15288\/jsad.2009.70.735","volume":"70","author":"W Barta","year":"2009","unstructured":"Barta W, Kurth M, Stein M, Tennen H, Kiene, SM. Craving and self-efficacy in the first five weeks of methadone maintenance therapy: A daily process study. J Stud Alcohol Drugs 2009;70(5):735\u201340.","journal-title":"J Stud Alcohol Drugs"},{"issue":"8","key":"BF03404152_CR10","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1056\/NEJMoa0810635","volume":"361","author":"E Oviedo-Joekes","year":"2009","unstructured":"Oviedo-Joekes E, Brissette S, Marsh DC, Lauzon P, Guh D, Anis A, Schechter MT. Diacetylmorphine versus methadone for the treatment of opioid addiction (Supplementary Appendix). N Engl J Med 2009;361(8):777\u201386.","journal-title":"N Engl J Med"},{"key":"BF03404152_CR11","volume-title":"Reaching the Hardest to Reach\u2013Treating the Hardest-to-Treat","author":"The NAOMI Study Team.","year":"2008","unstructured":"The NAOMI Study Team. Reaching the Hardest to Reach\u2013Treating the Hardest-to-Treat. Summary of the Primary Outcomes of the North American Opiate Medication Initiative (NAOMI), October 2008."},{"key":"BF03404152_CR12","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1016\/S0140-6736(10)60349-2","volume":"375","author":"J Strang","year":"2010","unstructured":"Strang J, Metrebian N, Lintzeris N, Potts L, Carnwath T, Mayet S, et al. Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): A randomised trial. Lancet 2010;375:1885\u201395.","journal-title":"Lancet"},{"issue":"1","key":"BF03404152_CR13","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.drugpo.2008.07.004","volume":"21","author":"JA Peterson","year":"2010","unstructured":"Peterson JA, Schwartz RP, Mitchell SG, Reisinger HS, Kelly SM, O\u2019Grady KE, et al. Why don\u2019t out-of-treatment individuals enter methadone treatment programmes? Int J Drug Policy 2010;21(1):36\u201342.","journal-title":"Int J Drug Policy"},{"issue":"6","key":"BF03404152_CR14","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1093\/aje\/kwp186","volume":"170","author":"B Nosyk","year":"2009","unstructured":"Nosyk B, MacNab Y, Sun H, Fischer B, Marsh DC, Schechter MT, Anis, AH. Proportional hazards frailty models for recurrent methadone maintenance treatment. Am J Epidemiol 2009;170(6):783\u201392.","journal-title":"Am J Epidemiol"},{"issue":"8","key":"BF03404152_CR15","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/S0006-3223(03)00290-7","volume":"54","author":"R Stoermer","year":"2003","unstructured":"Stoermer R, Drewe J, Dursteler-MacFarland KM, Hock C, Mueller-Spahn F, Ladewig D, et al. Safety of injectable opioid maintenance treatment for heroin dependence. Biol Psychiatry 2003;54(8):854\u201361.","journal-title":"Biol Psychiatry"},{"issue":"1","key":"BF03404152_CR16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0379-0738(99)00040-7","volume":"102","author":"SN Andersen","year":"1999","unstructured":"Andersen SN, Skullerud K. Hypoxic\/ischaemic brain damage, especially pallidal lesions, in heroin addicts. Forensic Sci Int 1999;102(1):51\u201359.","journal-title":"Forensic Sci Int"},{"issue":"2","key":"BF03404152_CR17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0376-8716(01)00199-5","volume":"66","author":"MF Goldstein","year":"2002","unstructured":"Goldstein MF, Deren S, Kang SY, Des Jarlais DC, Magura S. Evaluation of an alternative program for MMTP drop-outs: Impact on treatment re-entry. Drug Alcohol Depend 2002;66(2):181\u201387.","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"BF03404152_CR18","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0740-5472(03)00038-2","volume":"24","author":"RE Booth","year":"2003","unstructured":"Booth RE, Corsi KF, Mikulich, SK. Improving entry to methadone maintenance among out-of-treatment injection drug users. J Subst Abuse Treat 2003;24(4):305\u201311.","journal-title":"J Subst Abuse Treat"}],"container-title":["Canadian Journal of Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03404152.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03404152\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03404152.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T12:44:16Z","timestamp":1568378656000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03404152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["BF03404152"],"URL":"https:\/\/doi.org\/10.1007\/bf03404152","relation":{},"ISSN":["0008-4263","1920-7476"],"issn-type":[{"value":"0008-4263","type":"print"},{"value":"1920-7476","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}